Charles River Laboratories | CRL - Current Assets

Stock Price
203.62
Daily Change
-9.60 -4.50%
Monthly
-2.26%
Yearly
24.83%
Q1 Forecast
204.00

Charles River Laboratories reported $1.53B in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
Agilent USD 4.59B 341M Sep/2025
Align Technology USD 2.53B 86.04M Sep/2025
Bio-Rad Laboratories USD 2.84B 30.9M Sep/2025
Bruker USD 2.35B 187.9M Sep/2025
Cardinal Health USD 38.54B 2.16B Sep/2025
Charles River Laboratories USD 1.53B 62.24M Sep/2025
Cigna USD 46.74B 2.01B Sep/2025
CVS Health USD 77.11B 1.46B Sep/2025
Danaher USD 12.76B 3.15B Dec/2025
Dentsply International USD 2.07B 106M Sep/2025
Elevance Health USD 63B 777M Dec/2025
Galapagos EUR 3.16B 93.29M Sep/2025
Hologic USD 3.84B 175.3M Dec/2025
Humana USD 32.75B 863M Sep/2025
Illumina USD 2.8B 155M Sep/2025
Incyte USD 4.28B 634.19M Sep/2025
IQVIA Holdings USD 5.98B 366M Sep/2025
Laboratory Of America USD 4.08B 8.4M Sep/2025
Lonza CHF 5.44B 113M Dec/2024
McKesson USD 59.89B 3.09B Sep/2025
Merck EUR 12.88B 680M Sep/2025
Mettler Toledo International USD 1.28B 36.74M Sep/2025
Novartis USD 28.2B 2.26B Sep/2025
Pfizer USD 46.92B 3.22B Sep/2025
Quest Diagnostics USD 2.41B 209M Sep/2025
Revvity USD 2.14B 92.4M Sep/2025
Thermo Fisher Scientific USD 28.71B 6.41B Dec/2025
United Therapeutics USD 3.49B 332.9M Sep/2025
UnitedHealth USD 95.07B 1.37B Sep/2025
Waters USD 1.92B 137.07M Sep/2025
West Pharmaceutical Services USD 1.82B 142.4M Sep/2025